Panaccione, R.Colombel, J-F.Bossuyt, P.Baert, F.Vanasek, T.Danalioglu, A.Novacek, G.Armuzzi, A.Reinisch, W.Johnson, S.Buessing, M.Neimark, E.Petersson, J.Robinson, A. M.Thakkar, R. B.Lee, W-J.Skup, M.D'Haens, G.2020-10-222020-10-222018-02-01Panaccione R., Colombel J., Bossuyt P., Baert F., Vanasek T., Danalioglu A., Novacek G., Armuzzi A., Reinisch W., Johnson S., et al., -Long-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial-, JOURNAL OF CROHNS & COLITIS, cilt.12, 2018http://hdl.handle.net/20.500.12645/25000ArticleWOS:000427318900104